These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22004109)

  • 1. Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
    Schäfer C; Seeliger H; Bader DC; Assmann G; Buchner D; Guo Y; Ziesch A; Palagyi A; Ochs S; Laubender RP; Jung A; De Toni EN; Kirchner T; Göke B; Bruns C; Gallmeier E
    J Cell Mol Med; 2012 Aug; 16(8):1776-91. PubMed ID: 22004109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of unphosphorylated and phosphorylated heat shock protein 27 as a prognostic biomarker in pancreatic ductal adenocarcinoma.
    Drexler R; Wagner KC; Küchler M; Feyerabend B; Kleine M; Oldhafer KJ
    J Cancer Res Clin Oncol; 2020 May; 146(5):1125-1137. PubMed ID: 32200459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
    Guo Y; Ziesch A; Hocke S; Kampmann E; Ochs S; De Toni EN; Göke B; Gallmeier E
    J Cell Mol Med; 2015 Feb; 19(2):340-50. PubMed ID: 25331547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer.
    Okuno M; Yasuda I; Adachi S; Nakashima M; Kawaguchi J; Doi S; Iwashita T; Hirose Y; Kozawa O; Yoshimi N; Shimizu M; Moriwaki H
    Oncotarget; 2016 Mar; 7(12):14291-9. PubMed ID: 26895107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer.
    Drouillard A; Puleo F; Bachet JB; Ouazzani S; Calomme A; Demetter P; Verset G; Van Laethem JL; Maréchal R
    Br J Cancer; 2016 Nov; 115(10):1245-1252. PubMed ID: 27755532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.
    Wang W; Reiser-Erkan C; Michalski CW; Raggi MC; Quan L; Yupei Z; Friess H; Erkan M; Kleeff J
    Biochem Biophys Res Commun; 2010 Oct; 401(3):422-8. PubMed ID: 20863812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Xu P; Yao J; He J; Zhao L; Wang X; Li Z; Qian J
    Oncotarget; 2016 Mar; 7(12):14831-40. PubMed ID: 26894380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.
    Okuno M; Adachi S; Kozawa O; Shimizu M; Yasuda I
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer.
    Song Y; Ji B; Jiang CX; Chen ZM; Yao NH; Mukaida N; Huang H
    Pathol Res Pract; 2019 Dec; 215(12):152650. PubMed ID: 31585811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
    Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Itani M; Yoshioka T; Matsushima-Nishiwaki R; Hirose Y; Kozawa O; Moriwaki H
    Cancer Lett; 2011 Dec; 313(2):218-25. PubMed ID: 21999932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients.
    Richards NG; Rittenhouse DW; Freydin B; Cozzitorto JA; Grenda D; Rui H; Gonye G; Kennedy EP; Yeo CJ; Brody JR; Witkiewicz AK
    Ann Surg; 2010 Sep; 252(3):499-505; discussion 505-6. PubMed ID: 20739850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells.
    Kang D; Choi HJ; Kang S; Kim SY; Hwang YS; Je S; Han Z; Kim JH; Song JJ
    Cell Signal; 2015 Apr; 27(4):807-17. PubMed ID: 25615626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.
    Baylot V; Andrieu C; Katsogiannou M; Taieb D; Garcia S; Giusiano S; Acunzo J; Iovanna J; Gleave M; Garrido C; Rocchi P
    Cell Death Dis; 2011 Oct; 2(10):e221. PubMed ID: 22012255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of CD36 on Chemoresistance in Pancreatic Ductal Adenocarcinoma.
    Kubo M; Gotoh K; Eguchi H; Kobayashi S; Iwagami Y; Tomimaru Y; Akita H; Asaoka T; Noda T; Takeda Y; Tanemura M; Mori M; Doki Y
    Ann Surg Oncol; 2020 Feb; 27(2):610-619. PubMed ID: 31605325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas.
    Yang D; Shi J; Fu H; Wei Z; Xu J; Hu Z; Zhang Y; Yan R; Cai Q
    Tumour Biol; 2016 Sep; 37(9):12315-12327. PubMed ID: 27289231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.
    Wei L; Wen JY; Chen J; Ma XK; Wu DH; Chen ZH; Huang JL
    World J Gastroenterol; 2019 Oct; 25(37):5590-5603. PubMed ID: 31602160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7H4, HSP27 and DJ-1 molecular markers as prognostic factors in pancreatic cancer.
    Tsiaousidou A; Lambropoulou M; Chatzitheoklitos E; Tripsianis G; Tsompanidou C; Simopoulos C; Tsaroucha AK
    Pancreatology; 2013; 13(6):564-9. PubMed ID: 24280570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma.
    Xu X; Wang Y; Chen J; Ma H; Shao Z; Chen H; Jin G
    J Gastrointest Surg; 2012 Aug; 16(8):1493-8. PubMed ID: 22639377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
    Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.